Table 2 Clinical data of participants comparing the presence of DAN symptoms (SAS ≥ 3) vs. absence of DAN symptoms (SAS < 3)

Age ^a

54.00 (± 20.00)

56.00 (± 19.80)

48.00 (± 22.5)

0.002**

HbA1c ^a

7.70 (± 2.25)

7.97 (± 2.28)

7.50 (± 1.10)

0.043**

Time of DM ^a

14.00 (± 16.00)

14.00 (± 16.00)

16.00 (± 15.50)

1.000

Use of insulin ^b

52 (± 47.7)

31 (± 40.9)

21 (± 63.6)

0.028**

AC ^c

101.01 (± 14.37)

103.13 (± 14.58)

96.15 (± 12.80)

0.019**

BMI ^a

28.73 (± 6.70)

29.54 (± 7.5)

27.56 (± 5.10)

0.013**

Dyslipidemia ^b

72 (66.1)

55 (72.4)

17 (51.5)

0.035**

HDL ^c

48.45 (± 15.11)

47.43 (± 14.81)

50.92 (± 15.84)

0.333

Triglycerides ^a

137.00 (± 100.50)

151.00 (± 101.50)

102.00 (± 7.00)

0.072

SBP ^c

133.76 (± 19.23)

135.73 (± 19.44)

129.21(± 18.20)

0.104

DBP ^c

78.52 (± 11.32)

78.44 (± 11.86)

78.69 (± 10.15)

0.916

MS ^b

95 (87.2)

72 (94.7)

23 (69.7)

0.001**

Overweight

46 (42.2)

30(39.5)

16 (48.5)

0.381

Obesity

41 (37.6)

33 (43.4)

8 (24.2)

0.058